Michel Komajda

66.9k citations
355 papers · 26.8k indexed · 13 hit papers · h-index 77

Impact in

    • Heart Failure Treatment and Management
    • Cardiovascular Function and Risk Factors
    • Cardiac pacing and defibrillation studies
    • Cardiomyopathy and Myosin Studies
    • Heart rate and cardiovascular health
    • Cardiac electrophysiology and arrhythmias
    • Cardiovascular Effects of Exercise

Papers in

    • Heart Failure Treatment and Management 178
    • Cardiovascular Function and Risk Factors 95
    • Cardiac pacing and defibrillation studies 65
    • Heart rate and cardiovascular health 55
    • Cardiomyopathy and Myosin Studies 53
    • Blood Pressure and Hypertension Studies 26
    • Cardiac electrophysiology and arrhythmias 23
    • Atrial Fibrillation Management and Outcomes 20

Michel Komajda

342 papers receiving 25.8k citations

Hit Papers

Effect of Empagliflozin on Worsening Heart Failure Events in Patients With Heart Failure and Preserved Ejection Fraction: EMPEROR-Preserved Trial 2021 · 226 citations
226200320262010201850010001.5k

Peers

Michel Komajda
Comparison fields: 5 of 167
  • Cardiology and Cardiovascular Medicine 22.2k
  • Family Practice 621
  • Endocrinology, Diabetes and Metabolism 4.2k
  • Geriatrics and Gerontology 454
  • Complementary and alternative medicine 684
Replace Massimo Volpe with:
Massimo Volpe Italy
Marvin A. Konstam United States
Michael R. Zile United States
Mihai Gheorghiade United States
Luigi Tavazzi Italy
Mihai Gheorghiade United States
Henry Krum Australia
John Kjekshus Norway
L. Kristin Newby United States
Marco Metra Italy
Michel Komajda relative to Massimo Volpe Italy Massimo Volpe's profile →
Citations per field
00.5×1.5×1.9×
Massimo Volpe · 1×
Citations per year

Countries citing papers authored by Michel Komajda

Since Specialization
Citations

This map shows the geographic impact of Michel Komajda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Komajda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Komajda more than expected).

Fields of papers citing papers by Michel Komajda

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Komajda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Komajda. The network helps show where Michel Komajda may publish in the future.

Co-authors

The 25 scholars most cited alongside Michel Komajda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michel Komajda Line = papers co-authored together Michel Komajda links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20211
2
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
Hit paper breakdown →
20201204
3 201553
4 201551
5 201453
6 201419
7 201443
8 201437
9 201467
10 201335
11 201360
12 201323
13 201221
14 201222
15 201122
16 2010252
17 20099
18 200833
19 200812
20 200455

About Michel Komajda

Michel Komajda is a scholar working on Cardiology and Cardiovascular Medicine, Family Practice, Endocrinology, Diabetes and Metabolism, Complementary and alternative medicine and Geriatrics and Gerontology, having authored 355 papers that have together received 26.8k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (178 papers), Cardiovascular Function and Risk Factors (95 papers), Cardiac pacing and defibrillation studies (65 papers), Heart rate and cardiovascular health (55 papers), Cardiomyopathy and Myosin Studies (53 papers), Blood Pressure and Hypertension Studies (26 papers), Cardiac electrophysiology and arrhythmias (23 papers) and Atrial Fibrillation Management and Outcomes (20 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (22.2k citations), Family Practice (621 citations), Endocrinology, Diabetes and Metabolism (4.2k citations), Geriatrics and Gerontology (454 citations) and Complementary and alternative medicine (684 citations). Michel Komajda has collaborated with scholars based in France, United Kingdom and United States. Frequent co-authors include Karl Swedberg, Luigi Tavazzi, John J.V. McMurray, Michael Böhm, Jeffrey Borer, Ian Ford, John G.F. Cleland, Peter E. Carson, Michael R. Zile and Robert S. McKelvie. Their work appears in journals such as European Journal of Heart Failure, European Heart Journal, Journal of the American College of Cardiology, Circulation and Journal of Cardiac Failure.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026